The researchers used CRISPR/Cas9 to deactivate the Nrf2 gene in A549 cells by cutting the Neh4 and Neh5 domains in lung cancer cells which altered the Nrf2 nuclear export signal (NES) region. Here, NFE2L2 is linked to lung carcinoma.